Q&A: Improving liver cancer outcomes through enhanced immunotherapy
Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published in Cancer Immunology ...
Dec 16, 2024
0
35









